Seaport Res Ptn Has Pessimistic View of Innospec Q3 Earnings

Key Points

• Seaport Res Ptn has lowered its Q3 2025 earnings estimate for Innospec to $1.03 per share, down from $1.12, with a full-year earnings estimate now at $6.18 per share.
• Shares of Innospec have been downgraded by various analysts, with Wall Street Zen changing its rating from "buy" to "hold" and Zacks Research upgrading from "strong sell" to "hold."
• Currently, Innospec's stock has a market cap of $1.84 billion and is trading at $74.08, close to its 52-week low of $73.58.

Innospec Inc. (NASDAQ:IOSP - Free Report) - Analysts at Seaport Res Ptn lowered their Q3 2025 earnings estimates for Innospec in a note issued to investors on Friday, October 17th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will earn $1.03 per share for the quarter, down from their prior forecast of $1.12. The consensus estimate for Innospec's current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec's Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $5.08 EPS.

Other research analysts also recently issued research reports about the stock. Wall Street Zen downgraded shares of Innospec from a "buy" rating to a "hold" rating in a research report on Sunday. Zacks Research raised shares of Innospec from a "strong sell" rating to a "hold" rating in a research note on Monday, October 6th. Finally, Weiss Ratings raised shares of Innospec from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, Innospec currently has a consensus rating of "Moderate Buy".

Innospec Stock Down 0.1%

Shares of Innospec stock opened at $74.08 on Monday. The firm's 50 day moving average price is $81.31 and its 200-day moving average price is $84.54. Innospec has a 52-week low of $73.58 and a 52-week high of $128.35. The company has a market cap of $1.84 billion, a P/E ratio of 94.97 and a beta of 1.04.

Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.09. Innospec had a net margin of 1.08% and a return on equity of 10.89%. The company had revenue of $439.70 million during the quarter, compared to analyst estimates of $440.70 million. During the same period in the prior year, the firm earned $1.39 earnings per share. The firm's revenue for the quarter was up 1.1% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IOSP. Kirr Marbach & Co. LLC IN lifted its holdings in Innospec by 1.8% in the 1st quarter. Kirr Marbach & Co. LLC IN now owns 79,066 shares of the specialty chemicals company's stock valued at $7,492,000 after purchasing an additional 1,370 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Innospec by 0.8% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 2,404,825 shares of the specialty chemicals company's stock valued at $227,352,000 after purchasing an additional 19,018 shares in the last quarter. Tsfg LLC purchased a new position in Innospec in the 1st quarter valued at $35,000. ZWJ Investment Counsel Inc. lifted its holdings in Innospec by 6.6% in the 1st quarter. ZWJ Investment Counsel Inc. now owns 46,311 shares of the specialty chemicals company's stock valued at $4,388,000 after purchasing an additional 2,885 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in shares of Innospec by 2.4% during the 1st quarter. Principal Financial Group Inc. now owns 132,493 shares of the specialty chemicals company's stock valued at $12,554,000 after acquiring an additional 3,045 shares during the last quarter. Hedge funds and other institutional investors own 96.64% of the company's stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.